Literature DB >> 10225815

Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis.

Y Hatano1, T Kasama, H Iwabuchi, R Hanaoka, H T Takeuchi, L Jing, Y Mori, K Kobayashi, M Negishi, H Ide, M Adachi.   

Abstract

OBJECTIVE: To determine the contribution made by synovial fluid (SF) neutrophils to the augmented expression of macrophage inflammatory protein 1 alpha (MIP-1alpha) in rheumatoid arthritis (RA).
METHODS: Neutrophils were isolated from samples of SF from RA patients and peripheral blood (PB) samples from RA patients and healthy controls. Cell associated MIP-1alpha was visualised immunohistochemically, and cell associated MIP-1alpha as well as MIP-1alpha secreted into the SF was assayed by ELISA. Steady state expression of MIP-1alpha mRNA was assessed by reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: Freshly isolated SF neutrophils contained significantly higher concentrations of both MIP-1alpha protein and its transcript than PB neutrophils from either RA patients or healthy controls; incubation in the absence or presence of tumour necrosis factor alpha for 24 hours resulted in a significant increase in MIP-1alpha secretion by RA SF neutrophils compared with neutrophils obtained from either normal PB or RA PB; and expression of MIP-1alpha by SF neutrophils was well correlated with both RA disease activity and SF mononuclear cell (MNC) counts.
CONCLUSION: Expression and secretion of MIP-1alpha by SF neutrophils may be indicative of local and systemic inflammation in RA. Moreover, this C-C chemokine may contribute to the recruitment of MNCs from the bloodstream into synovial joints and tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225815      PMCID: PMC1752877          DOI: 10.1136/ard.58.5.297

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

Review 1.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

2.  Synovial tissue macrophage as a source of the chemotactic cytokine IL-8.

Authors:  A E Koch; S L Kunkel; J C Burrows; H L Evanoff; G K Haines; R M Pope; R M Strieter
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

3.  Cytokine regulation of IL-1 beta gene expression in the human polymorphonuclear leukocyte.

Authors:  P T Marucha; R A Zeff; D L Kreutzer
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

4.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.

Authors:  N A Cicco; A Lindemann; J Content; P Vandenbussche; M Lübbert; J Gauss; R Mertelsmann; F Herrmann
Journal:  Blood       Date:  1990-05-15       Impact factor: 22.113

6.  Human neutrophils exhibit disparate chemotactic factor gene expression.

Authors:  R M Strieter; K Kasahara; R Allen; H J Showell; T J Standiford; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

7.  Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; F Effenberger; G Haberhauer; H Broell; I J Lindley
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

8.  Cytokine-induced neutrophil-derived interleukin-8.

Authors:  R M Strieter; K Kasahara; R M Allen; T J Standiford; M W Rolfe; F S Becker; S W Chensue; S L Kunkel
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8.

Authors:  F Bazzoni; M A Cassatella; F Rossi; M Ceska; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.

Authors:  S R McColl; R Paquin; C Ménard; A D Beaulieu
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  16 in total

1.  Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA).

Authors:  T Kasama; K Kobayashi; N Yajima; F Shiozawa; Y Yoda; H T Takeuchi; Y Mori; M Negishi; H Ide; M Adachi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Neonatal neutrophils with prolonged survival secrete mediators associated with chronic inflammation.

Authors:  Caroline N Nguyen; Patricia M Schnulle; Nasser Chegini; Xiaoping Luo; Joyce M Koenig
Journal:  Neonatology       Date:  2010-06-10       Impact factor: 4.035

3.  Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.

Authors:  Boris K Pliyev; Mikhail Yu Menshikov
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

4.  Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines.

Authors:  Shivaprasad H Venkatesha; Brian Astry; Siddaraju M Nanjundaiah; Hua Yu; Kamal D Moudgil
Journal:  Bioorg Med Chem       Date:  2012-07-07       Impact factor: 3.641

5.  High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes.

Authors:  Isabel García-Arnandis; Maria Isabel Guillén; Francisco Gomar; Jean-Pierre Pelletier; Johanne Martel-Pelletier; Maria José Alcaraz
Journal:  Arthritis Res Ther       Date:  2010-08-27       Impact factor: 5.156

6.  Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.

Authors:  Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2011-07-08       Impact factor: 19.103

7.  Modified huo-luo-xiao-ling dan suppresses adjuvant arthritis by inhibiting chemokines and matrix-degrading enzymes.

Authors:  Siddaraju M Nanjundaiah; David Y-W Lee; Zhongze Ma; Harry H S Fong; Lixing Lao; Brian M Berman; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-07       Impact factor: 2.629

8.  Accelerated development of arthritis in mice lacking endothelial selectins.

Authors:  Jeffrey H Ruth; M Asif Amin; James M Woods; Xiaodong He; Sharon Samuel; Nengjun Yi; Christian S Haas; Alisa E Koch; Daniel C Bullard
Journal:  Arthritis Res Ther       Date:  2005-06-15       Impact factor: 5.156

9.  A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis.

Authors:  Ryosuke Hanaoka; Tsuyoshi Kasama; Mizuho Muramatsu; Nobuyuki Yajima; Fumitaka Shiozawa; Yusuke Miwa; Masao Negishi; Hirotsugu Ide; Hideyo Miyaoka; Hitoshi Uchida; Mitsuru Adachi
Journal:  Arthritis Res Ther       Date:  2003-01-06       Impact factor: 5.156

10.  RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming.

Authors:  Helen L Wright; Huw B Thomas; Robert J Moots; Steven W Edwards
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.